CJC-1295 + Ipamorelin + Sermorelin Cartridge for Injector Pen

🧬 Clinical Overview

What it is:

This triple-peptide blend layers three complementary GH-axis agents into a single formulation: Sermorelin and CJC-1295 both act on the GHRH receptor to elevate baseline growth hormone signaling, while Ipamorelin acts on a separate ghrelin receptor pathway to trigger a clean, pulsatile GH release. The result is a broader, more comprehensive stimulus to the GH axis than any single peptide or two-peptide combination.

Mechanism of Action:

Sermorelin and CJC-1295 both stimulate GHRH receptors, reinforcing baseline growth hormone signaling

Ipamorelin selectively stimulates the ghrelin receptor for a strong, clean GH pulse without significant cortisol or appetite impact

The layered approach maximizes natural GH and downstream IGF-1 output across two distinct receptor pathways

Preserves the body's natural feedback loop, reducing risk of GH excess relative to synthetic HGH